Key result
Opportunistic screening with a single-lead ECG device did not increase the detection of new atrial fibrillation cases compared to usual care.
Why the study?
AF increases risks of stroke, heart failure, and mortality, but may remain undiagnosed if asymptomatic; single-lead ECG devices may help GPs diagnose it.
Does opportunistic screening with a single-lead ECG device improve the detection of newly diagnosed atrial fibrillation in adults aged ≥65 years compared to usual care?
RCT (n=17,107)
Open-label
Cluster randomized
Yes
Does opportunistic screening with a single-lead ECG device improve the detection of newly diagnosed atrial fibrillation in adults aged ≥65 years compared to usual care?
Opportunistic screening for atrial fibrillation using a single-lead ECG device in primary care did not increase the detection rate of new AF cases compared to usual care.
Answers are grounded in this paper and cite their sources.
Opportunistic single-lead ECG screening does not increase new AF detection in primary care; challenges broad implementation and directs research to targeted strategies.
Background Atrial fibrillation (AF) increases the risk of stroke, heart failure, and all-cause mortality. AF may be asymptomatic and therefore remain undiagnosed. Devices such as single-lead electrocardiographs (ECGs) may help GPs to diagnose AF. Aim To investigate the yield of opportunistic screening for AF in usual primary care using a single-lead ECG device. Design and setting A clustered, randomised controlled trial among patients aged ≥65 years with no recorded AF status in the Netherlands from October 2014 to March 2016. Method Fifteen intervention general practices used a single-lead ECG device at their discretion and 16 control practices offered usual care. The follow-up period was 1 year, and the primary outcome was the proportion of newly diagnosed cases of AF. Results In total, 17 107 older people with no recorded AF status were eligible to participate in the study. In the intervention arm, 10.7% of eligible patients ( n = 919) were screened over the duration of the study year. The rate of newly diagnosed AF was similar in the intervention and control practices (1.43% versus 1.37%, P = 0.73). Screened patients were more likely to have comorbidities, such as hypertension (60.0% versus 48.7%), type 2 diabetes (24.3% versus 18.6%), and chronic obstructive pulmonary disease (11.3% versus 7.4%), than eligible patients not screened in the intervention arm. Among patients with newly diagnosed AF in intervention practices, 27% were detected by screening, 23% by usual primary care, and 50% by a medical specialist or after stroke/transient ischaemic attack. Conclusion Opportunistic screening with a single-lead ECG at the discretion of the GP did not result in a higher yield of newly detected cases of AF in patients aged ≥65 years in the community than usual care. For higher participation rates in future studies, more rigorous screening methods are needed.
No takes yet. Share an insight, caveat, or question.
Kaasenbrood et al. (2020) conducted an RCT in Atrial fibrillation (n=17,107). Opportunistic screening with a single-lead ECG device (MyDiagnostick) vs. Usual care was evaluated on Proportion of newly diagnosed cases of atrial fibrillation (OR 1.05, 95% CI 0.81 to 1.35, p=0.73). Opportunistic screening with a single-lead ECG device did not increase the detection of new atrial fibrillation cases compared to usual care.
Synapse has enriched 10 related papers. Consider them for comparative context: